Rino Rappuoli

Chief Scientist and Head External R&D, GSK

Rino’s contributions have had a phenomenal impact on the vaccines industry. He was involved in the development of CRM197 used in H.influenzae, N.meningitidis, and pneumococcus vaccines, and has also introduced several novel scientific concepts – genetic detoxification (1987), cellular microbiology (1996), reverse vaccinology (2000) and the pangenome (2005).

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019